The report will be delivered in 2-3 business days.

Biologics Global Market Report 2021: COVID-19 Impact and Recovery to 2030

Starting Price : $5000 | Pages : 400 | Published : December 2020 | SKU CODE : r373 | Format :


The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics to treat and prevent various microbial diseases and cancers. Biological products include a wide range of products such as vaccines, allergenics, somatic cells, tissues, and recombinant therapeutic proteins. This industry includes establishments that produce products that are composed of sugars, proteins, nucleic acids, and combination of all these substances isolated from humans, animal and microorganisms or produced from biotechnology methods. Specifically, most biologic medicines are developed using recombinant DNA (rDNA) technology. The biologics market is segmented into monoclonal antibodies (MAbs); therapeutic proteins; and vaccines.

The global biologics market is expected to grow from $253.41 billion in 2020 to $268.51 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $420.55 billion in 2025 at a CAGR of 12%.

North America was the largest region in the global biologics market, accounting for 53% of the market in 2020. Asia Pacific was the second largest region, accounting for 21% of the global biologics market. Africa was the smallest region in the global biologics market.

Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early.

The early generation of biologics is losing its patent protection and are expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are the pharmaceuticals that are developed to have similar properties to a biologic drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the ‘Guidelines on Similar Biologics’ prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase competitiveness for the biologics market putting downward pressure on pricing and market value growth.

The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure safety, purity and potency of biologics can now be obtained from sources other than the FDA’s Center for Biologics Evaluation and Research (CBER), or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) which specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products.

The major players covered in the global biologics market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, GlaxoSmithKline Plc., AbbVie.

The countries covered in the global biologics market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global biologics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global biologics market is segmented -

1) By Type: Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route Of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Subsegments Covered: Anti-Cancer MAbs, Immunological MAbs, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MAbs, Cardiovascular And Cerebrovascular MAbs, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines

    1. Executive Summary

    2. Report Structure

    3. Biologics Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Biologics Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Biologics Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Biologics Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Biologics Market Trends And Strategies

    8. Impact Of COVID-19 On Biologics

    9. Biologics Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Biologics Market Regional Analysis

    10.1. Global Biologics Market, 2020, By Region, Value ($ Billion)

    10.2. Global Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    10.3. Global Biologics Market, Growth And Market Share Comparison, By Region

    11. Biologics Market Segmentation

    11.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Monoclonal Antibodies (MAbS)

    Therapeutic Proteins

    Vaccines

    11.2. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Biologics Market Segments

    12.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) - Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs)

    12.2. Global Therapeutic Proteins Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins

    12.3. Global Vaccines Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) - Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines

    13. Biologics Market Metrics

    13.1. Biologics Market Size, Percentage Of GDP, 2015-2025, Global

    13.2. Per Capita Average Biologics Market Expenditure, 2015-2025, Global

    14. Asia-Pacific Biologics Market

    14.1. Asia-Pacific Biologics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    14.2. Asia-Pacific, Biologics Market, 2020, By Country, Value ($ Billion)

    14.3. Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    14.4. Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Asia-Pacific, Biologics Market Metrics

    14.5.1. Per Capita Average Biologics Expenditure, 2015-2025, Asia-Pacific Countries

    14.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries

    14.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries

    14.6. Asia-Pacific Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7. Asia-Pacific Biologics Market: Country Analysis

    14.7.1. China Biologics Market

    14.7.1.1. China Biologics Market Overview

    14.7.1.2. China Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.1.3. China Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.2. Australia Biologics Market

    14.7.2.1. Australia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.2.2. Australia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.3. Hong Kong Biologics Market

    14.7.3.1. Hong Kong Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.4. India Biologics Market

    14.7.4.1. India Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.4.2. India Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5. Indonesia Biologics Market

    14.7.5.1. Indonesia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5.2. Indonesia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6. Japan Biologics Market

    14.7.6.1. Japan Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6.2. Japan Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.7. Malaysia Biologics Market

    14.7.7.1. Malaysia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.8. New Zealand Biologics Market

    14.7.8.1. New Zealand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.9. Philippines Biologics Market

    14.7.9.1. Philippines Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.10. Singapore Biologics Market

    14.7.10.1. Singapore Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.11. South Korea Biologics Market

    14.7.11.1. South Korea Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.11.2. South Korea Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.12. Thailand Biologics Market

    14.7.12.1. Thailand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.13. Vietnam Biologics Market

    14.7.13.1. Vietnam Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15. Western Europe Biologics Market

    15.1. Western Europe Biologics Market Overview

    15.2. Western Europe, Biologics Market, 2020, By Country, Value ($ Billion)

    15.3. Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    15.4. Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. Western Europe, Biologics Market Metrics

    15.5.1. Per Capita Average Biologics Expenditure, 2015-2025, Western Europe Countries

    15.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries

    15.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries

    15.6. Western Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7. Western Europe Biologics Market: Country Analysis

    15.7.1. Austria Biologics Market

    15.7.1.1. Austria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.2. Belgium Biologics Market

    15.7.2.1. Belgium Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.3. Denmark Biologics Market

    15.7.3.1. Denmark Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4. Finland Biologics Market

    15.7.4.1. Finland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.5. France Biologics Market

    15.7.5.1. France Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.5.2. France Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.6. Germany Biologics Market

    15.7.6.1. Germany Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.6.2. Germany Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.7. Ireland Biologics Market

    15.7.7.1. Ireland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.8. Italy Biologics Market

    15.7.8.1. Italy Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.9. Netherlands Biologics Market

    15.7.9.1. Netherlands Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.10. Norway Biologics Market

    15.7.10.1. Norway Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.11. Portugal Biologics Market

    15.7.11.1. Portugal Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.12. Spain Biologics Market

    15.7.12.1. Spain Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.13. Sweden Biologics Market

    15.7.13.1. Sweden Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.15. Switzerland Biologics Market

    15.7.15.1. Switzerland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.15. UK Biologics Market

    15.7.15.1. UK Biologics Market2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.15.2. UK Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16. Eastern Europe Biologics Market

    16.1. Eastern Europe Biologics Market Overview

    16.2. Eastern Europe, Biologics Market, 2020, By Country, Value ($ Billion)

    16.3. Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    16.4. Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. Eastern Europe, Biologics Market Metrics

    16.5.1. Per Capita Average Biologics Expenditure, 2015-2025, Eastern Europe Countries

    16.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries

    16.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries

    16.6. Eastern Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7. Eastern Europe Biologics Market: Country Analysis

    16.7.1. Czech Republic Biologics Market,  

    16.7.1.1. Czech Republic Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.2. Poland Biologics Market

    16.7.2.1. Poland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3. Romania Biologics Market

    16.7.3.1. Romania Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.4. Russia Biologics Market

    16.7.4.1. Russia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.4.2. Russia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17. North America Biologics Market

    17.1. North America Biologics Market Overview

    17.2. North America, Biologics Market, 2020, By Country, Value ($ Billion)

    17.3. North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    17.4. North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. North America, Biologics Market Metrics

    17.5.1. Per Capita Average Biologics Expenditure, 2015-2025, North America Countries

    17.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries

    17.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries

    17.6. North America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7. North America Biologics Market: Country Analysis

    17.7.1. Canada Biologics Market

    17.7.1.1. Canada Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2. Mexico Biologics Market

    17.7.2.1. Mexico Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.3. USA Biologics Market

    17.7.3.1. USA Biologics Market Overview

    17.7.3.2. USA Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.3.3. USA Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18. South America Biologics Market

    18.1. South America Biologics Market Overview

    18.2. South America, Biologics Market, 2020, By Country, Value ($ Billion)

    18.3. South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    18.4. South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. South America, Biologics Market Metrics

    18.5.1. Per Capita Average Biologics Expenditure, 2015-2025, South America Countries

    18.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries

    18.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries

    18.6. South America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7. South America Biologics Market: Country Analysis

    18.7.1. Argentina Biologics Market

    18.7.1.1. Argentina Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.2. Brazil Biologics Market

    18.7.1.1. Brazil Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.2.2. Brazil Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.3. Chile Biologics Market

    18.7.3.1. Chile Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.4. Colombia Biologics Market

    18.7.4.1. Colombia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.5. Peru Biologics Market

    18.7.5.1. Peru Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.6. Venezuela Biologics Market

    18.7.6.1. Venezuela Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19. Middle East Biologics Market

    19.1. Middle East Biologics Market Overview

    19.2. Middle East, Biologics Market, 2020, By Country, Value ($ Billion)

    19.3. Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    19.4. Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    19.5. Middle East, Biologics Market Metrics

    19.5.1. Per Capita Average Biologics Expenditure, 2015-2025, Middle East Countries

    19.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries

    19.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries

    19.6. Middle East Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7. Middle East Biologics Market: Country Analysis

    19.7.1. Saudi Arabia Biologics Market

    19.7.1.1. Saudi Arabia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.2. Israel Biologics Market

    19.7.2.1. Israel Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.3. Turkey Biologics Market

    19.7.3.1. Turkey Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.4. UAE Biologics Market

    19.7.4.1. UAE Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20. Africa Biologics Market

    20.1. Africa Biologics Market Overview

    20.2. Africa, Biologics Market, 2020, By Country, Value ($ Billion)

    20.3. Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    20.4. Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    20.5. Africa, Biologics Market Metrics

    20.5.1. Per Capita Average Biologics Expenditure, 2015-2025, Africa Countries

    20.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries

    20.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries

    20.6. Africa Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20.7. Africa Biologics Market: Country Analysis

    20.7.1. Egypt Biologics Market

    20.7.1.1. Egypt Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20.7.2. Nigeria Biologics Market

    20.7.2.1. Nigeria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20.7.3. South Africa Biologics Market

    20.7.3.1. South Africa Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    21. Biologics Market Competitive Landscape

    21.1. Competitive Market Overview

    21.2. Market Shares

    21.3. Company Profiles

    21.3.1. Johnson & Johnson

    21.3.1.1. Company Overview

    21.3.1.2. Products And Services

    21.3.1.3. Strategy

    21.3.1.4. Financial Performance

    21.3.2. F. Hoffmann-La Roche Ltd.

    21.3.2.1. Company Overview

    21.3.2.2. Products And Services

    21.3.2.3. Strategy

    21.3.2.4. Financial Performance

    21.3.3. Bristol-Myers Squibb

    21.3.3.1. Company Overview

    21.3.3.2. Products And Services

    21.3.3.3. Strategy

    21.3.3.4. Financial Performance

    21.3.4. GlaxoSmithKline Plc.

    21.3.4.1. Company Overview

    21.3.4.2. Products And Services

    21.3.4.3. Strategy

    21.3.4.4. Financial Performance

    21.3.5. AbbVie

    21.3.5.1. Company Overview

    21.3.5.2. Products And Services

    21.3.5.3. Strategy

    21.3.5.4. Financial Performance

    22. Key Mergers And Acquisitions In The Biologics Market

    23. Market Background: Pharmaceuticals Market

    23.1. Pharmaceuticals Market Characteristics

    23.2. Pharmaceuticals Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    23.3. Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)

    23.4. Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    23.5. Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)

    24. Recommendations

    24.1. Global Biologics Market In 2025- Growth Countries

    24.2. Global Biologics Market In 2025- Growth Segments

    24.3. Global Biologics Market In 2025- Growth Strategies

    25. Appendix

    25.1. NAICS Definitions Of Industry Covered In This Report

    25.2. Abbreviations

    25.3. Currencies

    25.4. Research Inquiries

    25.5. The Business Research Company

    26. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Biologics Market, 2020, By Region, Value ($ Billion)
  • Table 4: Global Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Biologics Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 12: Global Therapeutic Proteins Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 13: Global Vaccines Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 14: Biologics Market Size, Percentage Of GDP, 2015-2025, Global
  • Table 15: Per Capita Average Biologics Market Expenditure, 2015-2025, Global
  • Table 16: Asia-Pacific, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 17: Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 18: Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 19: Per Capita Average Biologics Expenditure, 2015-2025, Asia-Pacific Countries
  • Table 20: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries
  • Table 21: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries
  • Table 22: Asia-Pacific Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 23: China Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 24: China Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 25: Australia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 26: Australia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 27: Hong Kong Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 28: India Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 29: India Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 30: Indonesia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 31: Indonesia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 32: Japan Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 33: Japan Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 34: Malaysia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 35: New Zealand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 36: Philippines Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 37: Singapore Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 38: South Korea Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 39: Thailand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 40: Vietnam Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 41: Western Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 42: Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 43: Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 44: Per Capita Average Biologics Expenditure, 2015-2025, Western Europe Countries
  • Table 45: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries
  • Table 46: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries
  • Table 47: Western Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 48: Austria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 49: Belgium Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 50: Denmark Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 51: Finland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 52: France Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 53: France Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 54: Germany Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 55: Germany Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 56: Ireland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 57: Italy Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 58: Netherlands Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 59: Norway Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 60: Portugal Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 61: Spain Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 62: Sweden Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 63: Switzerland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 64: UK Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 65: UK Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 66: Eastern Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 67: Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 68: Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 69: Per Capita Average Biologics Expenditure, 2015-2025, Eastern Europe Countries
  • Table 70: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries
  • Table 71: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries
  • Table 72: Eastern Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 73: Czech Republic Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 74: Poland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 75: Romania Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 76: Russia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 77: Russia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 78: North America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 79: North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 80: North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 81: Per Capita Average Biologics Expenditure, 2015-2025, North America Countries
  • Table 82: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries
  • Table 83: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries
  • Table 84: North America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 85: Canada Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 86: Mexico Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 87: USA Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 88: USA Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 89: South America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 90: South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 91: South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 92: Per Capita Average Biologics Expenditure, 2015-2025, South America Countries
  • Table 93: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries
  • Table 94: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries
  • Table 95: South America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 96: Argentina Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 97: Brazil Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 98: Brazil Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 99: Chile Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 100: Colombia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 101: Peru Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 102: Venezuela Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 103: Middle East, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 104: Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 105: Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 106: Per Capita Average Biologics Expenditure, 2015-2025, Middle East Countries
  • Table 107: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries
  • Table 108: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries
  • Table 109: Middle East Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 110: Saudi Arabia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 111: Israel Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 112: Turkey Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 113: UAE Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 114: Africa, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 115: Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 116: Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 117: Per Capita Average Biologics Expenditure, 2015-2025, Africa Countries
  • Table 118: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries
  • Table 119: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries
  • Table 120: Africa Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 121: Egypt Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 122: Nigeria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 123: South Africa Biologics Market2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 124: Johnson & Johnson Financial Performance
  • Table 125: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 126: Bristol-Myers Squibb Financial Performance
  • Table 127: GlaxoSmithKline Plc. Financial Performance
  • Table 128: AbbVie Financial Performance
  • Table 129: Pharmaceuticals Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 130: Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)
  • Table 131: Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 132: Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 133: Global Biologics Market In 2025- Growth Countries
  • Table 134: Global Biologics Market In 2025- Growth Segments
  • Table 135: Global Biologics Market In 2025- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Biologics Market, 2020, By Region, Value ($ Billion)
  • Figure 4: Global Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 5: Global Biologics Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 12: Global Therapeutic Proteins Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 13: Global Vaccines Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 14: Biologics Market Size, Percentage Of GDP, 2015-2025, Global
  • Figure 15: Per Capita Average Biologics Market Expenditure, 2015-2025, Global
  • Figure 16: Asia-Pacific, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 17: Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 18: Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 19: Per Capita Average Biologics Expenditure, 2015-2025, Asia-Pacific Countries
  • Figure 20: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries
  • Figure 21: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries
  • Figure 22: Asia-Pacific Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 23: China Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 24: China Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 25: Australia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 26: Australia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 27: Hong Kong Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 28: India Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 29: India Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 30: Indonesia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 31: Indonesia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 32: Japan Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 33: Japan Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 34: Malaysia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 35: New Zealand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 36: Philippines Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 37: Singapore Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 38: South Korea Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 39: Thailand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 40: Vietnam Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 41: Western Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 42: Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 43: Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 44: Per Capita Average Biologics Expenditure, 2015-2025, Western Europe Countries
  • Figure 45: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries
  • Figure 46: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries
  • Figure 47: Western Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 48: Austria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 49: Belgium Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 50: Denmark Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 51: Finland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 52: France Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 53: France Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 54: Germany Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 55: Germany Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 56: Ireland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 57: Italy Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 58: Netherlands Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 59: Norway Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 60: Portugal Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 61: Spain Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 62: Sweden Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 63: Switzerland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 64: UK Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 65: UK Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 66: Eastern Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 67: Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 68: Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 69: Per Capita Average Biologics Expenditure, 2015-2025, Eastern Europe Countries
  • Figure 70: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries
  • Figure 71: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries
  • Figure 72: Eastern Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 73: Czech Republic Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 74: Poland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 75: Romania Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 76: Russia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 77: Russia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 78: North America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 79: North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 80: North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 81: Per Capita Average Biologics Expenditure, 2015-2025, North America Countries
  • Figure 82: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries
  • Figure 83: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries
  • Figure 84: North America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 85: Canada Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 86: Mexico Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 87: USA Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 88: USA Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 89: South America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 90: South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 91: South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 92: Per Capita Average Biologics Expenditure, 2015-2025, South America Countries
  • Figure 93: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries
  • Figure 94: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries
  • Figure 95: South America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 96: Argentina Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 97: Brazil Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 98: Brazil Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 99: Chile Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 100: Colombia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 101: Peru Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 102: Venezuela Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 103: Middle East, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 104: Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 105: Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 106: Per Capita Average Biologics Expenditure, 2015-2025, Middle East Countries
  • Figure 107: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries
  • Figure 108: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries
  • Figure 109: Middle East Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 110: Saudi Arabia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 111: Israel Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 112: Turkey Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 113: UAE Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 114: Africa, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 115: Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 116: Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 117: Per Capita Average Biologics Expenditure, 2015-2025, Africa Countries
  • Figure 118: Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries
  • Figure 119: Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries
  • Figure 120: Africa Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 121: Egypt Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 122: Nigeria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 123: South Africa Biologics Market2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 124: Johnson & Johnson Financial Performance
  • Figure 125: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 126: Bristol-Myers Squibb Financial Performance
  • Figure 127: GlaxoSmithKline Plc. Financial Performance
  • Figure 128: AbbVie Financial Performance
  • Figure 129: Pharmaceuticals Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 130: Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)
  • Figure 131: Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 132: Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 133: Global Biologics Market In 2025- Growth Countries
  • Figure 134: Global Biologics Market In 2025- Growth Segments
  • Figure 135: Global Biologics Market In 2025- Growth Strategies
Global Bladder Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Bi-Specific MAbs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Biosimilar Therapeutic Peptides Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Biosimilar Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Arthritis Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Antiemetics And Antinauseants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Antifungals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)